Search research articles
Contact Us
Filters
Showing results (121-130 of 442) with videos related to
Page
of 45
Sort By:
JCI Insight
|
November 21, 2023
Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration
Arthur Liu, Seth T Gammon, Federica Pisaneschi, et al.
International Journal of Cancer
|
September 8, 2016
Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTER
Ishwaria M Subbiah, Jennifer J Wheler, Kenneth R Hess, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 19, 2014
Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes
Chad Tang, Zhongxing Liao, Daniel Gomez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 10, 2013
Genomic imprinting effects of the X chromosome on brain morphology
Jean-Francois Lepage, David S Hong, Paul K Mazaika, et al.
JAMA Dermatology
|
April 5, 2013
Merkel cell polyomavirus and HPV-17 associated with cutaneous squamous cell carcinoma arising in a patient with melanoma treated with the BRAF inhibitor dabrafenib
Gerald S Falchook, Peter Rady, Sharon Hymes, et al.
JAMA Network Open
|
November 25, 2024
Obesity and Outcomes in Adoptive Cellular Therapy in Solid Tumors
Derrick L Tao, Mirella Nardo, Cheuk Hong Leung, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 5, 2021
Translational pharmacokinetic-pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose
Wenyuan Xiong, Manja Friese-Hamim, Andreas Johne, et al.
Oncotarget
|
July 11, 2018
Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical trials with VEGF/VEGFR inhibitors
Ishwaria M Subbiah, Chad Tang, Arvind Rao, et al.
Hepato-Gastroenterology
|
May 15, 2012
Intraperitoneal and intravenous chemotherapy in peritoneal carcinomatosis
Apostolia M Tsimberidou, Siqing Fu, Ishwaria M Subbiah, et al.
Journal of Autism and Developmental Disorders
|
March 22, 2021
Effects of X Chromosome Monosomy and Genomic Imprinting on Observational Markers of Social Anxiety in Prepubertal Girls with Turner Syndrome
Scott S Hall, Matthew J Riley, Robyn N Weston, et al.
Page
of 45
Search research articles
Search
Showing results (121-130 of 442) with videos related to
Sort By:
Page
of 45
JCI Insight
|
November 21, 2023
Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration
Arthur Liu, Seth T Gammon, Federica Pisaneschi, et al.
International Journal of Cancer
|
September 8, 2016
Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTER
Ishwaria M Subbiah, Jennifer J Wheler, Kenneth R Hess, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 19, 2014
Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes
Chad Tang, Zhongxing Liao, Daniel Gomez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 10, 2013
Genomic imprinting effects of the X chromosome on brain morphology
Jean-Francois Lepage, David S Hong, Paul K Mazaika, et al.
JAMA Dermatology
|
April 5, 2013
Merkel cell polyomavirus and HPV-17 associated with cutaneous squamous cell carcinoma arising in a patient with melanoma treated with the BRAF inhibitor dabrafenib
Gerald S Falchook, Peter Rady, Sharon Hymes, et al.
JAMA Network Open
|
November 25, 2024
Obesity and Outcomes in Adoptive Cellular Therapy in Solid Tumors
Derrick L Tao, Mirella Nardo, Cheuk Hong Leung, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 5, 2021
Translational pharmacokinetic-pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose
Wenyuan Xiong, Manja Friese-Hamim, Andreas Johne, et al.
Oncotarget
|
July 11, 2018
Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical trials with VEGF/VEGFR inhibitors
Ishwaria M Subbiah, Chad Tang, Arvind Rao, et al.
Hepato-Gastroenterology
|
May 15, 2012
Intraperitoneal and intravenous chemotherapy in peritoneal carcinomatosis
Apostolia M Tsimberidou, Siqing Fu, Ishwaria M Subbiah, et al.
Journal of Autism and Developmental Disorders
|
March 22, 2021
Effects of X Chromosome Monosomy and Genomic Imprinting on Observational Markers of Social Anxiety in Prepubertal Girls with Turner Syndrome
Scott S Hall, Matthew J Riley, Robyn N Weston, et al.
Page
of 45